SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001790340-23-000048
Filing Date
2023-08-03
Accepted
2023-08-03 16:10:19
Documents
67
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q imrx-20230630.htm   iXBRL 10-Q 1511579
2 EX-10.1 imrx-20230630xex101nedcomp.htm EX-10.1 20613
3 EX-31.1 imrx-20230630xex311.htm EX-31.1 10260
4 EX-31.2 imrx-20230630xex312.htm EX-31.2 10380
5 EX-32.1 imrx-20230630xex321.htm EX-32.1 5123
6 EX-32.2 imrx-20230630xex322.htm EX-32.2 5264
  Complete submission text file 0001790340-23-000048.txt   5797416

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT imrx-20230630.xsd EX-101.SCH 35871
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT imrx-20230630_cal.xml EX-101.CAL 57840
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT imrx-20230630_def.xml EX-101.DEF 200034
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT imrx-20230630_lab.xml EX-101.LAB 464311
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT imrx-20230630_pre.xml EX-101.PRE 328596
61 EXTRACTED XBRL INSTANCE DOCUMENT imrx-20230630_htm.xml XML 647365
Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Filer) CIK: 0001790340 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40675 | Film No.: 231140031
SIC: 2834 Pharmaceutical Preparations